2 ms·
Also, here are some more quotes on the influence of commercial funding, showing indirectly that the file drawer effect combined with the methodology produces re
by Alex3917 14y ago
Also, here are some more quotes on the influence of commercial funding, showing indirectly that the file drawer effect combined with the methodology produces results that are much more biased and of poorer quality than non-profit funded studies.
"Studies repeatedly document bias in commercially sponsored research, but the medical journals seem powerless to control the scientific integrity of their own pages. In 2003, separate studies were published in JAMA and the <i>British Medical Journal</i> showing that the odds are 3.6 to 4 times greater that commercially sponsored studies will favor the sponsor's products than studies without commercial funding. And in August of 2003 a study published in JAMA found that among the highest-quality clinical trials, the odds that those with commercial sponsorship will recommend the new drug are 5.3 times greater than for studies funded by non-profit organizations. The authors noted that the lopsided results of commercially sponsored research may be 'due to biased interpretation of trial results.' They cautioned that readers should 'carefully evaluate whether conclusions in randomized trials are supported by data.' In other words, doctors are warned that even the best research published in the best journals <i>cannot</i> be taken at face value." Source: Overdose America, p. 97. Citing <a href="http://www.ncbi.nlm.nih.gov/pubmed/12533125>Scope http://www.ncbi.nlm.nih.gov/pubmed/12533125>Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A systematic Review</a>, <a href="http://www.bmj.com/content/326/7400/1167.full>Pharmaceutical http://www.bmj.com/content/326/7400/1167.full>Pharmaceut... Industry Sponsorship and Research Outcome and Quality: A Systematic Review</a>, <a href="http://jama.jamanetwork.com/article.aspx?articleid=197132>Association http://jama.jamanetwork.com/article.aspx?articleid=197132... of Funding and Conclusions in Randomized Drug Trials</a>
"In the case of calcium channel blockers like Norvasc, for instance, one survey of seventy articles about their safety found that 96 percent of authors who were supportive of the drugs had financial ties to the companies that made them, whereas only 37 percent of authors who were critical had such ties." Source: The Truth About Drug Companies, p. 107, citing <a href="http://www.nejm.org/doi/full/10.1056/NEJM199801083380206>Conflict http://www.nejm.org/doi/full/10.1056/NEJM199801083380206>... of Interest in the Debate over Calcium Channel Antagonists</a>
"A team of reserachers at the Beth Israel Medical Center in New York have examined the outcome of clinical trials as a function of who had sponsored them. They found that approximately 75 per cent of drug-company studies showed favourable results for their own drugs, but only 25 per cent of them showed favourable results for the product of a competing company. In studies that are not sponsored by a drug company, the success rate is approximately 50 per cent." Source: The Emperor's New Drugs, p. 62, describing <a href="http://journals.cambridge.org/action/displayAbstract;jsessionid=8791B742923B6F462F07F977A080DEFB.journals?fromPage=online&aid=522832>Relationship http://journals.cambridge.org/action/displayAbstract;jsessio... between drug company funding and outcomes of clinical psychiatric research</a>
See also:
http://jama.jamanetwork.com/article.aspx?articleid=202867 http://jama.jamanetwork.com/article.aspx?articleid=202867
http://www.ncbi.nlm.nih.gov/pubmed/17550302 http://www.ncbi.nlm.nih.gov/pubmed/17550302
- Symmetry 14y agoI'm certainly willing to believe that groups can be biased towards a drug that they're affiliated with, I just doubt that the effect is smaller if it's being developed by their university as opposed to their corporation. But I should note, you can also explain that data in terms of corporations being biased towards paying studies on those drugs most likely to succeed. That is, it could be that on those drugs that are most good corporations paid for a larger share of the studies than for those drugs that are least good. Now, I expect that if you did on study on, for a given drug, corporate funded studies would still be disproportionately likely to find the drug good - but to a less extend than the paper you cite since humans are biased creatures after all.